Supplier News Breaks Archives

Week of Mon, Dec 10th, 2012

AstraZeneca: Crestor U.S. patent is upheld

AstraZeneca reported that the Court of Appeals for the Federal Circuit has upheld a decision of the U.S. District Court in Delaware that the substance patent protecting its cholesterol-lowering drug Crestor is "valid and enforceable."

SoloHealth kiosk sees sharp rise in consumer use

SoloHealth reported that its SoloHealth Station health and wellness kiosk has seen consumer engagement surge over 200% since late summer.

Elite announces supply pact for phentermine API

Elite Pharmaceuticals Inc. has shored up its supply of phentermine active ingredient for the next year.

Markwins wraps up Physicians Formula acquisition

Markwins International has completed its purchase of Physicians Formula Holdings Inc., a deal valued at about $75 million.

Emerson Group names new partners

The Emerson Group has named Clark Tyndall, Sue Smith and Brian Schaefer as new partners.

Nexafed decongestant thwarts illegal meth makers

Acura Pharmaceuticals Inc. has launched Nexafed, a nasal decongestant with a technology that disrupts the conversion of pseudoephedrine into the dangerous drug methamphetamine.

Pepsi inks landmark deal with Beyoncé

PepsiCo has entered wide-ranging global partnership singing superstar and model Beyoncé that the beverage giant said marks a new way that it teams with musical artists.